EODData

FRA, 6NQ: BIOMED-LUBLIN WYT.SUR.

06 Feb 2026
LAST:

0.8900

CHANGE:
 0.01
OPEN:
0.8900
HIGH:
0.8930
ASK:
0.0000
VOLUME:
0
CHG(%):
1.55
PREV:
0.9040
LOW:
0.8900
BID:
0.0000
 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
06 Feb 260.89000.89300.89000.89000
05 Feb 260.89700.90400.89700.90400
04 Feb 260.90900.91200.90800.91200
03 Feb 260.90000.91300.90000.91300
02 Feb 260.92700.93700.90100.90100
30 Jan 260.92700.93700.92400.92400
29 Jan 260.93500.93900.93500.93700
28 Jan 260.93400.94500.93400.93800
27 Jan 260.92900.94900.92900.94900
26 Jan 260.92500.94600.92500.93400

PROFILE

Name:BIOMED-LUBLIN WYT.SUR.
About:Synthaverse S.A., a pharmaceutical company, manufactures and sells medicinal preparations, medical devices, and laboratory reagents in Poland, rest of the European Union, and internationally. It operates through BCG and Traditional segments. The company offers OnkoBCG 50 and 100, which are oncological immunotherapy products used to treat superficial and non-invasive bladder tumors; GAMMA anty-D 50 and GAMMA anty-D 150, which are human anti-rh0(d) immunoglobulin products used in the prevention of maternal-fetal conflict in terms of the D antigen with the Rh system; GAMMA anty HBs 200 medications for use in passive prophylaxis hepatitis B virus; and BCG 10 tuberculosis vaccines. It also provides Distreptaza, a gynecology and proctology reagent used in medical laboratories, in case of poisoning with pesticides and biochemical and chemical-analytical tests; LAKCID, which is a lactobacillus probiotic drug; and pseudocholinoesteraza, which is a laboratory reagent. In addition, the company engages in the contract production of injection drugs, lyophilisates of active substances in sterile sealed vials, active substances and drugs based on surface and submerged biological culture, and suppository forms of drugs. The company was formerly known as BIOMED-LUBLIN Wytwórnia Surowic i Szczepionek S.A. and changed its name to Synthaverse S.A. in July 2023. Synthaverse S.A. was founded in 1944 and is headquartered in Lublin, Poland.
Sector:Healthcare
Industry:Biotechnology
Address:ul. Uniwersytecka 10, Lublin, Poland, 20-029
Website:https://synthaverse.com
ISIN:PLBMDLB00018
LEI:259400OWZM67D079S374

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

FUNDAMENTALS

Trailing P/E:94.40 
PEG Ratio:0.06 
Price to Sales:3.49 
Price to Book:0.47 
Profit Margin:0.07 
Operating Margin:0.18 
Return on Assets:0.02 
Return on Equity:0.04 
Revenue:17.03M 
EBITDA:3.03M 
Shares:70.77M 
Market Cap:62.99M 

TECHNICAL INDICATORS

MA5:0.901.6%
MA10:0.923.4%
MA20:0.945.4%
MA50:0.890.2%
MA100:0.945.6%
MA200:1.0618.5%
RSI14:33.33 
WPR14:-100.00 
MTM14:-0.04
ROC14:-0.05 
ATR:0.02 
Week High:0.945.3%
Week Low:0.890.0%
Month High:1.0012.1%
Month Low:0.8918.5%
Year High:1.3855.2%
Year Low:0.7125.5%